Dr. Jeffrey K. Luttrull

HIGH SCHOOL:

Buena High School - Ventura, California   9/71 - 12/73

COLLEGE & UNIVERSITY:

Ventura Junior College

Ventura, California 6/73 - 9/73, 1/74 - 6/74

University of California at Santa Barbara, California

9/74 - 12/75 - Major: Music, Performance

University of California at Los Angeles, California

6/75 - 9/75

Point Loma College

San Diego, California   1/76 - 6/78 - Major: Chemistry

B.A., Chemistry; Magna Cum Laude

MEDICAL SCHOOL:

University of Southern California School of Medicine

Los Angeles, California - M.D., 1982

INTERNSHIP:

L.A. County - USC Medical Center

Flexible Type "C" (Ophthalmology)

Los Angeles, California   6/82- 3/86

RESIDENCY:

Resident in Ophthalmology

University of Southern California School of Medicine

Department of Doheny Eye Foundation

Los Angeles, California   7/83 - 6/86

FELLOWSHIPS:

Research Assistant in Chemistry

Research Associates of Point Loma College

Point Loma College

San Diego, California   6/76 - 9/76, 6/77 - 9/77

Research Assistant in Ophthalmology

University of Southern California

School of Medicine, Department of Ophthalmology

Estelle Doheny Eye Foundation

Los Angeles, California   3/82 - 7/82

Clinical Fellow

Vitreo-Retinal Diseases and Surgery

Devers Eye Clinic

Good Samaritan Hospital & Medical Center

Oregon Lions Sight & Hearing Institute

Portland, Oregon   7/86 - 1/88

Consultant

Vitreo-Retinal Diseases and Surgery

Inland Eye Institute

Associated Eye Specialists

Loma Linda, California   1/88 -9/89

Consultant

Vitreo-Retinal Diseases and Surgery

Ventura County Retina and Vitreous Medical Group,

Ventura, California   5/88 - present

Director

Retina Diagnostic Laboratory of Ventura County

Ventura, California   5/88 – present

Medical Director 

Vision Protection Institutes

California and Florida

National Eye Institute Association for Research in Vision and Ophthalmology Travel Fellowship, 1982

Intercollegiate Soccer Varsity Letter 1976-78, Point Loma College; Jr Varsity 1975 University of California Santa Barbara 

"Lillian and Henry Nesburn Award for Research Excellence", 1985. Annual award competition for

residents of Los Angeles ophthalmology training programs.

LA County/USC Department of Ophthalmology "Senior Resident of the Year, 1986" (Semi-Annual        teaching award presented by the Department of Ophthalmology junior residents)

President’s Award, Point Loma College. Alumni award for support of undergraduate sciences.

Scientific peer reviewer - ophthalmic peer review journals.

Alumnus Award, Point Loma Nazarene University, 2007.

Honor Award, American Society of Retinal Specialists, 2012.

American Academy of Ophthalmology Lifetime Member

Knight of Malta (Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta) 2015

“Top Doctor” Award 

European Society of Retina Specialists Amsterdam Retina Debate 2017

California: State License #G50280 2/88 -

Oregon: State License #14711 Active 6/86 -

Florida: State Florida #ME 152425 Active 8/17/21 –

Arizona: State License #644521 Active 10/15/21-

Utah: State License #12521318-1205 Active 11/2/21 –

Texas: State License # T9443 Active 8/19/22 –

National Board of Medical Examiners Parts I, II and III.

Passed; completed 1983.

American Board of Ophthalmology,

Lifetime certification October 1988.

California Medical Association

American Medical Association

Ventura County Medical Society

Member, Board of Directors, Retinitis Pigmentosa Foundation International, Ventura County Chapter, 1989

California Association of Ophthalmology, 1983 - 1997, 2007 

Association for Research in Vision and Ophthalmology, 1982, 1984, 1994

Fellow, American Academy of Ophthalmology, 1983- present. Life Member

Research Associates of Point Loma College, 1978 - present

Member, Board of Directors, Research Associates

of Point Loma College, 1985 - 1990

Chairman, Board of Directors, Research Associates of Point Loma College, 1988 - 1989

Member, American Diabetes Association, 1988 to 1995.

Member, Western Retina Study Club, 1989 to present.

Member, Ventura County Ophthalmology Society, 1989 to present

Founder and President, Ventura County Ophthalmology Society, 1989 - 1990

Advisor, California Medical Association Scientific Advisory Panel on Ophthalmology, 1990 -1994

Delegate, Leadership Conference, American Academy of Ophthalmology, Atlanta, October 1990   

Member, Santa Barbara Medical Society, 1993- 1996

Member, Santa Barbara Eye Society 1993-1996

Member, Board of Directors, American Diabetes Association, Ventura County Chapter, 1993

Member, Surgery Committee, St. John's Regional Medical Center 1994-98

Founder and Secretary, Board of Directors, Coastal Counties Eye Care Medical Group, Inc. (Regional Specialty IPA) 1994-2001.  

Assistant Vice-President for Ophthalmology Practice and Managed Care, California Association of Ophthalmology, 1995 - 1997.   

Member, Humanitarians, Catholic Healthcare West / St. Johns Regional Medical Center Foundation, 1996 - 

Co-founder and Secretary, Board of Directors, Premier Management Services, Inc.  Management Services Organization.1998 - 2001

Member, International Trumpet Guild. 1998 - 2011

President and Chairman of Board of Directors, Coastal Counties Medical Specialists Medical Group, Inc. 2001 - 2004.

Member, American Society of Retinal Specialists 2003 – Current. Honor Award recipient. 

Member, European Society of Retina Specialists 2010- Current

Founder, COO, Chairman BOD of Regalo Extra Virgin Olive Oil, Inc. 

Member, Board of Directors, Hearts of Fire Project 2007-2010 

Member, Faculty Research Review Board, Point Loma Nazarene University

Managing Member, Ojai Retinal Technologies, LLC

CE0 / CMO Retinal Protection Sciences, LLC

Member, Christian Scientific Society

Founder, Executive Director, LIGHT: The International Retinal Laser Society 2014-; Member BOD 2014-

Chairman, BOD, LIGHT 2014-2017

Ventura Community Memorial Hospital

Ventura, California - Courtesy  1988-2016

St. John's Regional Medical Center

Oxnard, California. – Courtesy 1988-

Cottage Hospital, Santa Barbara, California – Consulting 1993-2000

Ventura County Medical Center - Courtesy 1988-2006.

Spanish

As leader:

“From nothing”. Jazz. Producer Mark Craig. 2010 (Spotify link:  "From Nothing")

As soloist:

“Reflections of Bethlehem” 2009. Producer Mark Craig

As a sideman:

“Christmas in Cali” 2012. Producer Dominic Balli

1. Acute Retinal Necrosis Syndrome.  Annual Clinical Conference, USC Department of Ophthalmology, Doheny Eye Institute, 12/16/83.

2. Ocular Manifestations of the New Acquired Immunodeficiency Syndrome.  Annual Clinical Conference, USC Department of Ophthalmology, Doheny Eye Institute, 12/16/83.

3. Contractility of Avascular Corneal Wound Tissue In-Vitro in Animal Model.  Eighth Annual Residents, Fellows and Alumni Day, USC Department of Ophthalmology, Doheny Eye Institute, 6/22/84.

4. Ocular Emergencies.  Trauma Conference, Dept. of Emergency Medicine, LAC/USC Medical Center, 6/8/84.

5. Luttrull, J.K., Feldon, S.E., Adult Diabetic Papillopathy.  Ninth Annual Residents, Fellows and Alumni Day, USC Dept. of Ophthalmology, Doheny Eye Institute, 6/21/85.

6. Luttrull, J.K., Feldon, S.E.,: Transantral Orbital Decompression for Dysthyroid Optic Neuropathy.  Accepted for presentation to the International Orbital Society, Amsterdam, Netherlands, 9/85.

7. Hertzog, L.M., Luttrull, J.K., Chen, A., Feldon, S.E., Sadun, A.A.:  Anterior Ischemic Optic Neuropathy and Optic Disc Changes Associated with Hyperopia.  Presented to the American Academy of Ophthalmology Annual Meeting, New Orleans, 1986.

8. Dreyer, R.F., Luttrull, J.K.:  Angiographic Hot Spots.  Presented to the Oregon Academy of Ophthalmology Meeting, Portland, Oregon, 2/27/87.

9. Freeman, W.R., Chen, A., Henderly, D., Luttrull, J.K., Leung, R., Arthur, J.B., Urrea, P.T.: Prognostic and Systemic Significance of Non-Infectious AIDS Associated Retinopathy.  Presented to The Association for Research in Vision and Ophthalmology Annual Meeting, Sarasota, Florida, May 1987.

10. Luttrull, J.K., Dreyer, R.F.:  Angiographic Hot Spots:  Important Indicators of Occult Subretinal Neovascularization in A.M.D.  Presented to the Eleventh Annual Residents, Fellows, and Alumni Day, U.S.C. Department of Ophthalmology, Estelle Doheny Eye Foundation, Los Angeles, Calif., 6/5/87.

11. Dreyer, R.F., El Baba, F.Z., Luttrull, J.K.:  Sequential Retinal Tears as a Complication of Pneumatic Retinopexy. Presentation to the American Board of Ophthalmology Annual Meeting, Dallas, 1987.

12. El Baba, F.Z., Luttrull, J.K., Chenoweth, R.G., Dreyer, R.F.:  Bent-tip Endoilluminator for Anterior Vitreous Dissections From the Pars Plana.  Presentation to the American Academy of Ophthalmology Annual Meeting, Dallas, 1987.

13. Luttrull, J.K., Dreyer, R.F.:  Angiographic Hot Spots:  Important Indicators of Occult Subretinal Neovascularization in Age-Related Macular Degeneration.  Paper presentation to the American Academy of Ophthalmology Annual Meeting, Dallas, 1987.

14. Luttrull, J.K.:  Update on Treatable Macular Disease/Vitreous Surgery presented to the Inland Optometric Association Annual Ski Meeting, Mammoth Mountain, California, 2/26/88.

15. Luttrull, J.K.:  Brief Review of Common Retinal Vascular Disorders.  Ventura Community Memorial Hospital, 11/21/88.

16. Luttrull, J.K.:  Update on Common Retinal Disorders.  St. John's Regional Medical Center, 1/17/89.

17. Luttrull, J.K.:  Diabetic Retinopathy - Review.  Tri County Optometric Association, 3/11/89.

18. Luttrull, J.K.:  Differential Diagnosis of Retinal Disease, Tri County Optometric Association, 10/90.

19. Luttrull, J.K., Chittum, M.E.:  Acute-Acute Retinal Pigment Epitheliitis.  Western Retina Study Club, San Francisco, California, 03/17/93.

20. Luttrull, J.K., Wan, W.L., Oster, H.A.:  Treatment of Intraocular Fungal Infections with Diflucan.  Western Retina Study Club, San Francisco, California, 03-17-93.

21. Luttrull, J.K., Dreyer, R.F.:  Angiographic Hot Spots: Markers of Occult Choroidal Neovascularization.  Western Retina Study Club, San Francisco, California, 03/18/93.

22. Luttrull, J.K.:  Macular Hole Surgery - Prognostic Indicators.  Western Retina Study Club, San Francisco, California, 03/18/93.

23. Luttrull, J.K.:  Inadvertent Ocular Perforations and Intraocular Injections - Invited Speaker, "Cataract Surgery and Its Complications",  California Association of  Ophthalmology 12th Annual Educational Conference, 9/10 - 12/93, San Francisco, California.

24. Luttrull, J.K.:  Pseudophakic Cystoid Macular Edema Complicating Macular Hole Surgery. Western Retina Study Club, Phoenix, Arizona, 1/28/94.

25. Avery R.L., Luttrull JK:  Pars Plana Seton Implants for Treatment of Complicated Glaucomas.  Assoc. for Research in Vision and Ophthalmology, paper presentation, Sarasota, Florida, 03-15-94

26. Avery, R.L., Luttrull, J.K.:  Pars Plana Seton Implants for treatment of Complicated Glaucomas.  John Hopkins Hospital, Wilmer Eye Institute, Baltimore, Maryland, Annual Alumni Meeting, March 1994.

27. Luttrull, J. K., Avery, R.L.: Pars Plana Seton Implants and Vitrectomy for Neovascular Glaucoma.  Invited Speaker, Retina Free Paper Section, Annual Meeting, American Academy of Ophthalmology, San Francisco California, November 3, 1994.

28. Kim, J., MacDonald, H.R., Luttrull, J.K.:  Surfing-related ocular injuries.  Paper, Western Retina Study Club, Napa Valley, April 1997.

29. Luttrull, J.K.:  Specialty IPA Formation and Physician Reimbursement - A History of Coastal Counties Eye Care Medical Group.  Invited lecturer, National Coalition of IPA Administrators, Annual Meeting, Santa Barbara, California, March 26, 1997.

30. Baerveldt, G., Luttrull J.K.: Baerveldt Glaucoma Implant with Hofmann pars plana elbow. American Glaucoma Society 1997. Chicago, Ill., December 6, 1997.

31. Luttrull, J.K.: Pars Plana Modified Baerveldt Implant with Pneumatic Stent.  Instructional video tape presentation for Pharmacia-Upjohn.

32. Luttrull JK: Progressive Circumpapillary MEWDS.  Western Retina Study Club March 19, 1998, Monterey, Calif.

33. Luttrull JK, Avery RL, Baerveldt G: Initial Experience with Pneumatically Stented Baerveldt Implant Modified for Pars Plana Insertion. Western Retina Study Club March 20, 1998, Monterey, Calif.

34. Luttrull, JK: Laser pointer induced macular injury. Western Retina Study Club March 20, 1998, Monterey, Calif.

35. Avery RL, Luttrull JK: Initial experience with pneumatically stented pars plana modified Baerveldt implant for treatment of complicated glaucoma.  ARVO, May, 1998. 

36. Avery RL, Luttrull JK: Initial experience with pneumatically stented pars plana modified Baerveldt implant for treatment of complicated glaucoma.  Vitreous Society, May 1998.

37. Luttrull JK, Avery RL, Baerveldt G.S.:  Initial experience with pneumatically stented pars plana modified Baerveldt implant for treatment of complicated glaucoma.  Free paper presentation, Glaucoma Section, American Academy of Ophthalmology Annual Meeting, New Orleans, La., November 11, 1998.

38. Luttrull JK: Pneumatically stented implant procedure for complicated glaucoma.  Video presentation in “Surgical Innovations in Vitreoretinal Surgery, 1998”, Harry Flynn, M.D., “Frontiers of Vitreoretinal Surgery”, New Orleans, La., November 7, 1998.

39. Luttrull JK: A perspective on the role of research and publication in the career of a solo private practice physician.  Invitational alumnus lecture, Point Loma Nazarene University Departments of Biology and Chemistry.  June 25, 1999.  San Diego, CA.

40. Luttrull JK: Diode Micropulse Laser in Treatment of Retinal Vascular disease. Invited speaker, “Speaker’s Forum”, Iridex Corporation, American Academy of Ophthalmology, Orlando Florida, October 21, 2002.

41. Luttrull JK: Subthreshold Diode Micropulse Photocoagulation for the treatment of Clinically Significant Diabetic Macular Edema. Invited speaker, “Speaker’s Forum”, Iridex Corporation, American Academy of Ophthalmology, New Orleans LA, October 26, 2004.

42. Luttrull JK, Spink CA: Serial Optical Coherence Tomography of Atraumatic Subthreshold Diode Micropulse Photocoagulation for Diabetic Macular Edema. American Society of Retina Specialists, Annual Meeting, July 17 2005, Montreal Canada.

43. Luttrull JK: Update on subthreshold diode micropulse photocoagulation for diabetic macular edema. Invited speaker, Speaker's Forum, Iris Medical / Iridex Laser Corp. Annual meeting of American Academy of Ophthalmology, Chicago, Ill, October 16, 2005.

44. Luttrull JK, Musch DA, Spink CJ: Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Joint meeting of American Society of Retinal Specialists and European Vitreoretinal Society. Cannes, France, September 11, 2006 (poster).

45. Luttrull JK, Spink CJ: Prolonged choroidal hypofluorescence following verteporfin photodynamic therapy combined with intravitreal triamcinolone acetonide injection. Joint meeting of American Society of Retinal Specialists and European Vitreoretinal Society. Cannes, France, September 9, 2006.

46. Luttrull JK: Subthreshold diode micropulse photocoagulation for retinal vascular disease. Seven year experience. Invited speaker, Speaker's Forum, Iris Medical / Iridex Laser Corporation, American Academy of Ophthalmology annual meeting, New Orleans, LA, November 11, 2007.

47. Luttrull JK. Vitrectomy following anti-VEGF therapy for  epiretinal membrane coincident with age-related subfoveal neovascularization. Poster presentation to the annual meeting of American Society of Retinal Specialists, Palm Springs, CA, December 1, 2007. 

48. Luttrull JK. Subthreshold diode micropulse photocoagulation for retinal vascular disease. Why isn't everybody doing it?  By invitation: Stanford University School of Medicine, Department of Ophthalmology Grand Rounds. Palo Alto, CA, January 15, 2008.

49. Luttrull JK. Subthreshold diode micropulse photocoagulation for retinal vascular disease: 8 years experience. "Doheny Days"; Annual meeting of the Doheny Eye Institute, USC Dept of Ophthalmology, Los Angeles, CA, June 13, 2008.

50. Luttrull JK. Subthreshold diode micropulse photocoagulation for retinal vascular disease. By invitation: University of London, King's College Hospital, Dept of Ophthalmology, Grand Rounds. London, England, May 15, 2009.

51. Luttrull JK, Dougherty PJ, Zhao H, Mainster MA:

Concentric ring dysphotopsias in diffractive multifocal pseudophakia. European Society of Cataract and Refractive Surgery Annual Meeting, Barcelona, Spain, Sept. 14, 2009 free paper.

52. Luttrull JK, Dougherty PJ, Zhao H, Mainster MA:

Concentric ring dysphotopsias in diffractive multifocal pseudophakia. Combined meeting of the American Society of Retinal Specialists, Macula Society, and Retina Society, New York, New York, Sept 30, 2009 poster.

53. Luttrull JK. Subthreshold diode micropulse photocoagulation for retinal vascular disease. By invitation, Iridex Corp. Speakers Forum, San Francisco, California, Oct. 25, 2009.

54. Invited faculty, "Innovations of Laser for Vitreoretinal Disease Management". Hospital de Olhos, Sao Paolo, Brazil March 2 - 8, 2010.

55. Luttrull JK: Subthreshold diode micropulse photocoagulation for retinal vascular disease. 10 year experience. Innovations of Laser for Vitreoretinal Disease Management, Hospital de Olhos, Sao Paulo, Brazil. March 5, 2010.

56. Luttrull JK: Laser treatment for retinal vascular disease in the pharmacologic era. 10 year experience. Innovations of Laser for Vitreoretinal Disease Management, Hospital de Olhos, Sao Paulo, Brazil. March 5, 2010.

57. Luttrull JK: Clinical characteristics of subthreshold diode micropulse photocoagulation for retinal vascular disease. Innovations of Laser for Vitreoretinal Disease Management, Hospital de Olhos, Sao Paulo, Brazil. March 5, 2010. 

58. Luttrull JK: Pars plana vitrectomy with multiple transvenous chorioretinotomies for central retinal vein occlusion. Western Retina Study Club, LAICRS, UCLA Jules Stein Eye Institute, March 18, 2011.

59. Luttrull JK: Pars plana vitrectomy with multiple transvenous chorioretinotomies for central retinal vein occlusion. Retina “Masters” course, annual meeting of the American Society of Retina Specialists, Boston, MA, August 23 2011.

60. Luttrull JK, Spink CJ: Pars plana vitrectomy with multiple transvenous chorioretinotomies for macular edema complicating retinal vein occlusion. Poster.  Annual meeting of the American Society of Retina Specialists, Boston, MA, August 22 2011.

61. Sinclair S, Cardillo J, Luttrull JK: Subthreshold micropulse photocoagulation for diabetic macular edema. Instructor, clinical course. Annual meeting of the American Society of Retina Specialists, Boston, MA, August 23 2011.

62. Luttrull JK. Subvisible diode micropulse photocoagulation for retinal vascular disease. Clinical use. 11year experience. For Iridex Corporation at annual meeting of the American Academy of Ophthalmology, Orlando, Florida, Oct 23 2011.

63. Luttrull JK.  Subvisible diode micropulse photocoagulation for retinal vascular macular edema. Long-term safety, high-resolution imaging, tissue temperature modeling and dosimetry. For Iridex Corporation at annual meeting of the American Academy of Ophthalmology, Orlando, Florida, Oct 24 2011.

64. Luttrull, JK. Vitrectomy with transvenous chorioretinotomy for retinal vein occlusion. Paper presentation, Annual meeting of the American Society of Retina Specialists, Las Vegas, Nevada, August 26, 2012.

65. Luttrull, JK. Vitrectomy with transvenous chorioretinotomy for retinal vein occlusion. Paper presentation, European Society of Retina Specialists, Euretina annual meeting, Sept 9, 2012, Milan, Italy.

66. Luttrull JK, Sinclair SD, Midena E. Instructors in clinical course, American Society of Retina Specialists annual meeting, Toronto, Canada, August 27, 2013.

67. Luttrull JK, Sinclair SD. Safety of transfoveal subthreshold diode micropulse laser for intra-foveal diabetic macular edema in eyes with good visual acuity. Free paper presentation, American Society of Retina Specialists, Toronto, Canada, August 28, 2013. 

68. Keunen J, Luttrull JK, Chong V, Midena E, Boon C. Clinical instructors for course in Subthreshold diode micropulse laser for d iabetic macular edema. European Society of Retina Specialist annual meeting, Hamburg, Germany, Sept 27, 2013. 

69. Luttrull JK. Laser re-sensitization of medically unresponsive neovascular age-related macular degeneration. Efficacy and Implications. Extended Free Paper, Annual meeting of the American Society of Retinal Specialists, San Diego, CA, Aug 12, 2014.

70. Keunen J, Luttrull JK, Chong V, Midena E, Boon C. Clinical instructors for course in Subthreshold diode micropulse laser for diabetic macular edema. European Society of Retina Specialist annual meeting, Euretina, London, UK, September 2014.

71.  Keunen J, Luttrull JK, Chong V, Midena E, Boon C. Clinical instructors for course in Subthreshold diode micropulse laser for diabetic macular edema. European Society of Retina Specialist annual meeting, Euretina, Nice, France, September 14, 2015.

72. Luttrull JK, Margolis BWL. Prompt improvement in macular function following panmacular subthreshold diode micropulse laser (SDM) retinal protection as prophylaxis for age-related and inherited retinal degenerations. A model for functionally guided disease management. Free paper, Annual Meeting of the European Retina Society, Nice, France, Sept 17, 2015. 

73. Luttrull JK, Margolis BWL. Prompt improvement in macular function following panmacular subthreshold diode micropulse laser (SDM) retinal protection as prophylaxis for age-related and inherited retinal degenerations. A model for functionally guided disease management. Free paper, American Society of Retina Specialists, Annual Meeting, Vienna, Austria, July 11, 2015.

74. Luttrull JK, Margolis BWL. Functionally guided retinal protective therapy as prophylaxis for high-risk age-related and inherited retina degenerations. Free paper, Annual Meeting of LIGHT: The International Retinal Laser Society, Las Vegas, NV, November 12, 2015.

75. Luttrull, JK. Subthreshold diode micropulse laser (SDM) for central serous chorioretinopathy. Free paper, Annual Meeting of LIGHT: The International Retinal Laser Society, Las Vegas, NV, November 12, 2015.

76. Luttrull JK. Retinal protective therapy for chronic progressive retinopathies. Association for Research in Vision and Ophthalmology Annual Meeting, Retinal restorative treatment Special Interest Group. Presenter and panelist, Seattle, May 4, 2016.

77. Luttrull JK. Subthreshold diode micropulse laser treatment. Instructor, European School for Advanced Studies in Ophthalmology, Rome, Italy, February 15, 2016. 

78. Luttrull JK. Subthreshold diode micropulse laser (SDM) as retinal protective therapy for non age-related retinal degenerations. Free paper; Annual Meeting of the American Society of Retina Specialists, San Francisco, August 14, 2016.

79. Luttrull JK, Keunen J, Midena E. Instructors in course on: Subthreshold retinal laser treatment. European Retina Society annual meeting Euretina, September 2016. 

80. Luttrull JK. SDM retinal protective therapy reduces the risk of CNV in AMD. Annual meeting of the International Retinal Laser Society, Chicago, October 13, 2016. 

81. Sinclair SH, Luttrull JK. SDM retinal protective therapy in dry AMD improves visual function by OmnifieldTM mesoptc resolution automated perimetry. Annual meeting of the International Retinal Laser Society, Chicago, October 13, 2016. 

82. Moderator, AMD session 2, Euretina, European Retinal Society Annual Meeting, Sept 9, 2016, Copenhagen.

83. Luttrull JK. Hunter’s Syndrome: How the experience of transfoveal laser in a surgeon’s 20/15 eye informs laser dosimetry. The Int. Retinal Laser Soc. Annual Meeting, Oct. 13, 2016. 

84. Luttrull JK. Safety makes all the difference: Retinal laser treatment as the future of blindness prevention. Invited plenary / keynote speaker, International Society of Laser Safety and American Laser Institute. Atlanta, Georgia, March 20, 2017.

85. Luttrull, JK Panmacular SDM as neuroprotective therapy for POAG. Poster and abstract, ARVO annual meeting, 2017, Baltimore, MD, May 11, 2017.

86. Luttrull JK, Elmann S, Glaser B. Reduced incidence of choroidal neovascularization following subthreshold diode micropulse laser in dry AMD. Annual meeting of the American Society of Retina Specialists August 2017, Boston Mass.

87.  Luttrull JK, Elmann S, Glaser B. Reduced incidence of choroidal neovascularization following subthreshold diode micropulse laser in dry AMD. Annual meeting of the International Retinal Laser Society, Sept 6, 2017, Barcelona, Spain.

88. Sinclair SH, Luttrull JK. Mesoptic visual function following subthreshold diode micropulse laser for dry AMD. Annual meeting of the International Retinal Laser Society, Sept 6, 2017, Barcelona, Spain.

89. Luttrull JK, Blachley T. Real World Evidence of reduced anti-VEGF medication dependence following subthreshold diode micropulse laser in wet AMD. Annual meeting of the International Retinal Laser Society, Sept 6, 2017, Barcelona, Spain.

90.  Keunen J, Pilotto E, Chong V, Luttrull JK. Subthreshold laser for retinal diseases: concepts and future directions. Annual meeting of the European Society of Retina Specialists (Euretina) 2017; Instructional course Sept 10, Barcelona, Spain. 

91. Luttrull JK. Invited plenary speaker, “Amsterdam Retina Debate”. Annual meeting of the European Society of Retina Specialists (Euretina) 2017; Sept 8, Barcelona, Spain.

92. Luttrull JK, Boon C. Moderators Vitreoretinal Surgery IV, Annual meeting of the European Society of Retina Specialists (Euretina) 2017; Sept 10, Barcelona, Spain.

93. Luttrull JK, Keunen J. Moderators, Retinal vascular disease paper session 3, Annual meeting of the European Society of Retina Specialists (Euretina) 2017; Sept 22, Vienna, Austria.

94. Keunen J, Chong V, Midena E, Luttrull JK. Course, subthreshold laser surgery. Annual meeting of the European Society of Retina Specialists (Euretina) 2017; Sept 22, Vienna, Austria.

95. Luttrull, JK. Management of diabetic macular edema. Annual meeting, International Retinal Laser Society, Chicago, October 25, 2018.

96. Luttrull, JK. Total Retinal laser Therapy (TRT) for diabetic retinopathy: A treatment strategy fitting a retinopathy. Annual meeting, International Retinal Laser Society, Chicago, October 25, 2018.

97. Luttrull, JK. Unusual applications of sublethal retinal laser treatment. Annual meeting, International Retinal Laser Society, Chicago, October 25, 2018.

98. Luttrull, JK. Long-term results of SDM Retinal Protective Therapy for chronic progressive retinopathies. Annual meeting, International Retinal Laser Society, Chicago, October 25, 2018.

99. Luttrull JK. Modern Retinal Laser. Keynote address, Filatov Lecture, Ukraine Ophthalmology Society Biannual Meeting, Odessa, Ukraine, May 24, 2019.

100. Luttrull JK. SDM laser management of diabetic retinopathy. Ukraine Ophthalmology Society Biannual Meeting, Odessa, Ukraine, May 24, 2019.

101. Luttrull JK. Modern Retinal Laser. Moorfields Eye Hospital, Abu Dhabi, UAE, May 27, 2019.

102. Luttrull JK. Modern Retinal Laser. Moorfields Eye Hospital, Dubai, UAE, May 28, 2019.

103. Luttrull JK, Sinclair SH, Elmann S, Chang BD. Slowed progression of age-related geographic atrophy following panmacular subthreshold diode micropulse laser. International Retinal Laser Society Annual Meeting, Paris, France, Sept. 4, 2019.

104. Luttrull JK, Boucher, N. Real World Data: Retinal Protective Therapy improves all AMD outcomes. International Retinal Laser Society Annual Meeting, Paris, France, Sept. 4, 2019.

105. Chang DB, Luttrull JK. Comparison of 810nm to 577nm sublethal laser HSP activation dynamics. International Retinal Laser Society Annual Meeting, Paris, France, Sept. 4, 2019.

106. Luttrull JK. Modern Retinal Laser Management of Diabetic Macular Edema. Instruction course, Subthreshold Laser Treatment, Annual Meeting of the European Retina Society, Paris, France, Sept. 5, 2019.

107. Luttrull JK, Gray G. RWD analysis of subthreshold diode pulsed laser effects on neovascular conversion and injection frequency in AMD. Poster presentation to the annual meeting of the American Society of Retina Specialists virtual meeting July, 2020. 

108. Luttrull JK, Gray G. RWD analysis of subthreshold diode pulsed laser effects on neovascular conversion and injection frequency in AMD. Free paper presentation to the annual meeting of the European Society of Retina Specialists EURETINA, Amsterdam, The Netherlands, October 2, 2020. Virtual.

109. Slowed progression of age-related geographic atrophy following subthreshold laser. Free paper presentation to the annual meeting of the European Society of Retina Specialists EURETINA, Amsterdam, The Netherlands, October 2, 2020. Virtual.

110. Grzybowski A, Luttrull JK, Kozak I, Korol A, Gaweki M, Midena E. Retinal laser treatment. Virtual instructional course. Annual meeting of the European Society of Retina Specialists EURETINA September 12, 2021.

111. Luttrull JK, Gray G, Bhavan SV. Vision Protection Therapy Superior to Standard Care for Prevention of Neovascular AMD: Report No. 3. Annual meeting America Society of Retina Specialists, Seattle, Washington, July 28, 2023.

112. Luttrull JK, Gray G, Bhavan SV. Vision Protection Therapy Superior to Standard Care for Prevention of Neovascular AMD: Report No. 3. Annual meeting European Society of Retinal Specialists, Amsterdam, October 6, 2023.

113. Luttrull JK, Gray G, Bhavan SV. Vision Protection Therapy Superior to Standard Care for Prevention of Neovascular AMD: Report No. 3. Annual meeting LIGHT: The International Retinal Laser Society, Dec 2, 2023.

114. Luttrull JK, Tzekov R, Bhavan SV. Improved nerve fiber layer and ganglion cell complex thickness trends with SDM vision protection therapy. Evidence of clinical (CNS) neuroregeneration. Annual meeting European Society of Retinal Specialists, Amsterdam, October 6, 2023.

115. Luttrull JK, Tzekov R, Bhavan SV. Improved nerve fiber layer and ganglion cell complex thickness trends with SDM vision protection therapy. Evidence of clinical (CNS) neuroregeneration. Annual meeting LIGHT: The International Retinal Laser Society, Dec 2, 2023.

116. Luttrull JK, Bhavan SV. Improved standardized automated perimetry following vision protection therapy for open angle glaucoma and other optic atrophies. Annual meeting LIGHT: The International Retinal Laser Society, Dec 2, 2023.

117. Luttrull JK. Modern Retinal Laser Therapy. Keynote speaker, Slovak Ophthalmology Society Interactive Course on Modern Retinal Laser. Bratislava, Slovakia, April 5 2024. 

118. Luttrull JK. Modern Retinal Laser Therapy. Keynote speaker, Filatov Ophthalmology Institute annual meeting, Odesa, Ukraine, May 17 2024.

1. Shellhammer, D.F., Heasley, V.L., Foster, J.E., Luttrull, J.K., Heasley, G.E.:  Addition to 2,4 Dienes.  Halogenation of Ethyl Sorbate.  J. Org. Chem. 42:2141 (1977).

2. Shellhamer, D.F., Heasley, V.L., Foster, J.E., Luttrull, J.K., Heasley, G.E.:  Addition to 2,4 Dienes.  Ionic and Radical Additions to Ethyl Sorbate.  J. Org. Chem. 43:2652 (1978).

3. Shellhamer, D.F., Green, R.C., Luttrull, J.K., Seneker, S.D., Potter, M.K., Heasley, V.L., Heasley, G.E.:  Ionic and Radical Addition of Chlorine, Bromine, and Some Halogen Systems to Butadiene Monoxide. J. Heterocyclic Chem. 20:229 (1983).                                      

4. Jester, J.V., Rife, L., Nii, D., Luttrull, J.K., Wilson, L., Smith, R.E.:  In-Vitro Biomicroscopy and Photography of Meibomian Glands in a Rabbit Model of Meibomian Gland Dysfunction.  Invest. Ophthalmol., Vol. 22, No.5, 660-7, May 1982.

5. Luttrull, J.K., Jester, J.V., Smith, R.E.:  The Effect of Radial Keratotomy on Ocular Integrity in an Animal Model. Arch. Ophthalmol., 100:319-20, 1982.

6. Shellhamer DF, Green RC, Luttrull J, Seneker SD, Potter MK, Heasely VL, Heasley GE. Ionic and radical addition of chlorine, bromine,  and some halogen systems to butadiene monoxide. J of Heterocyclic Chem, Jan 1983. DOI: 10.1002/jhet.5570200147

7. Luttrull J.K, Jester J.V., Smith R.E. Radial Keratotomy – Reply. Arch. Ophthalmol,1983; 101(1):134-134.

8. Luttrull, J.K., Smith, R.E., Jester, J.V.:  Contractility of Avascular Corneal Wound Tissue in Rabbits.  Invest. Ophthal. Vol. 26, No.10, Oct. 1985, 1440-1452.

9. Freeman, W.R., Chen, A., Henderly, D.E., Levine, A.M., Luttrull, J.K., Urrea, P.T., Arthur, J.B., Rasheed, S., Cohen, J.L., Newberg, D., Leung, R.J.:  Prevalence and Significance of Acquired Immunodeficiency Syndrome - Related Retinal Microvasculopathy.  Am. J. Ophthalmol. 107:229-235, March, 1989.

10. Hallin, E.S., Feldon, S.E., Luttrull, J.K.: Effect of Transantral Orbital Decompression on Optic Neuropathy, Graves' Ophthalmopathy, Br. J. Ophthalmol. 72:683-687, 1988.

11. Luttrull, J.K.:  Macular Surgery. Western Journal of Medicine Vol. 157, No. 4, 449-450, 1992.

12. Luttrull, J.K., Wan, W.L., Kubak, B., Smith, M.D., Oster, H.A..:  Treatment of Ocular Fungal Infections with Oral Fluconazole. Am. J. Ophthalmol. 1995. 119:477-481.

13. Luttrull, JK, Chittum ME.: Acute Retinal Pigment Epitheliitis. Am. J. Ophthalmol. 1995. 120:389 - 391.

14. Luttrull, J.K., Avery, R. L.: Pars Plana Implant and Vitrectomy for Treatment of Neovascular Glaucoma. RETINA. 1995. 15: 379 -387.

15. Luttrull, J.K.: Acute Retinal Pigment Epitheliitis.  Am. J. Ophthalmol. 1997.123: 127 - 129.

16. Luttrull, J.K.: Epiretinal membrane and traction retinal detachment complicating laser-induced chorioretinal venous anastomosis. Am. J. Ophthalmol. 1997, 123: 698 -699.

17. Luttrull JK, Avery RL: Peripheral Transscleral Retinal Diode Laser for Rubeosis Iridis.  (Letter) Retina 18: 389, 1998.

18. Kim, W.K., McDonald H.R., Rubsamen P.E., Luttrull J.K., Drouilhet J.H., Frambach D.A., Boyer D.S., Lambrou F.H. Jr., Hendrick A., Weiss J.N., Engstrom R.E. Jr., Ing M.  Surfing-Related Ocular Injuries.  RETINA 18: 424-429, 1998.

19. Luttrull JK, Hallisey J: Laser pointer- induced macular injury.  Am.  J.  Ophthalmol.  1999; 127: 95 -96.

20. Luttrull JK, Marmor M, Nanda M: Progressive confluent peripapillary multiple evanescent white-dot syndrome.  Am. J. Ophthalmol. 1999; 128: 378-380.

21. Luttrull JK, Avery RL, Baerveldt G.S, Easley, K.:  Initial experience with pneumatically stented pars plana modified Baerveldt implant for treatment of complicated glaucoma.  Ophthalmology, 2000; 107:143-150.

22. Luttrull JK, Avery RL: “Augmentation of trabeculectomy with perfluoropropane gas: a pilot clinical and experimental study”.  (Letter) Ophthalmology, 2000; 107: 224.

23. Luttrull JK, Musch MC, Mainster MA:  Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular edema. Br J Ophthalmol 2005 89:1; 74-80.

24. Luttrull JK, Spink CJ: Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema. Ophthalmic Surgery, Lasers & Imaging, Sept/Oct 2006;37: 370-377.

25. Luttrull JK, Dougherty PJ. Reduced stereopsis during vitreous surgery for epiretinal membrane through Rezoom multifocal intraocular lens (letter). J  Refract Surg 2007 April; 23 (4) 329-330.

26.  Luttrull JK, Spink CJ, Musch DA. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye, 2008 May; 22 (5): 607 – 12. 

27. Luttrull JK, Spink CJ. Prolonged choroidal hypofluorescence following verteporfin photodynamic therapy combined with intravitreal triamcinolone acetonide injection.  RETINA, 2007 Jul-Aug, 27 (6): 688-92.

28. Luttrull JK, Spink CJ: Vitrectomy following anti-VEGF therapy for epiretinal membranes coincident with age-related subfoveal neovascularization. . 2008; 39: 455 - 459.

29. Luttrull JK, Musch D, Spink CJ: Subthreshold diode micropulse photocoagulation for proliferative diabetic retinopathy. Letter (Reply) Eye. Advance online publication Jan 2009; doi: 10.1038/eye.2008.418

30. Luttrull JK, Dougherty PJ, Zhao H, Mainster MA: Concentric ring dysphotopsias in diffractive multifocal pseudophakia. July 27, 2010.  Ophthalmic Surgery, Lasers and Imaging. 2010 Sep 29;41 Online. doi: 10.3928/15428877-20100929-11.

31. Luttrull JK, Sramek C, Palanker D, Spink CJ, Musch DC. Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina 2012; 32 (2): 375-86.

32. Luttrull JK, Dorin G. Subthreshold diode micropulse photocoagulation as invisible retinal phototherapy for diabetic macular edema. A review. Current Diabetes Reviews, 2012, 8, 274-284. 

33. Luttrull JK, Spink CJ. Pars plana vitrectomy with multiple transvenous chorioretinotomies for macular edema due to retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul 1;44(4):366-73.

34. Luttrull JK, Sinclair SD. Safety of transfoveal subthreshold diode micropulse laser for intra-foveal diabetic macular edema in eyes with good visual acuity. Retina, May 2014 Oct; 34 (10): 2010-20.

35. Luttrull JK, Chang DB, Margolis BWL, Dorin G, Luttrull DK. Laser re-sensitization of medically unresponsive neovascular age-related macular degeneration: Efficacy and implications. Retina 2015 Jun; 35(6): 1184-1194.

36. Kozak I, Luttrull JK. Modern Retinal Laser Therapy. Saudi J Ophthalmol 2015 Apr-Jun; 29 (2) 137-46.

37. Luttrull JK. Chronic serous macular detachments and visual disturbance complicating consecutive cases of symptomatic vitreomacular adhesion with macular hole treated with ocriplasmin. OSLI Retina, 2015; 46: 976-978.

38. Luttrull JK, Margolis BWL. Functionally guided retinal protective therapy as prophylaxis for age-related and inherited retinal degenerations. A pilot study. Invest Ophthalmol Vis Sci. 2016 Jan 1;5 7(1):265-75. doi: 10.1167/iovs.15-18163

39. Luttrull JK. Low-intensity / high-density subthreshold diode micropulse laser (SDM) for central serous chorioretinopathy. Retina. 2016 Sep; 36 (9):1658-63

40. Chhablani J, Roh YJ, Jobling AI, Fletcher EL, Lek JJ, Bansal P, Guymer R, Luttrull JK. Restorative retinal laser therapy: Present state and future directions. Surv. Ophthalmol 2018 May - Jun;63(3):307-328.

41. Jhingan M, Goud A, Peguda HK, Tyagi M, Luttrull JK, Chhablani J. Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study. Clinical Ophthalmology 2018:12 141–145.

42. Luttrull JK. Improved retinal and visual function following subthreshold diode micropulse laser (SDM) for retinitis pigmentosa. Eye (London) Feb 2018 PAP open access https://doi.org/10.1038/s41433-018-0017-3

43. Luttrull JK, Sinclair SH, Elmann S, Glaser BM. Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) for high-risk AMD. PLoS ONE 2018 13(8): e0202097. https://doi.org/10.1371/ journal.pone.0202097

44. Luttrull JK. "Comment on: van Rijssen TJ, van Dijk EHC, Scholz P, et al. PLACE Trial Report No. 3." (Letter) Am J Ophthalmol 2020 Apr; 212:186-187.

45. Chang DB, Luttrull JK. Comparison of subthreshold 577nm and 810nm micropulse laser effects on heat-shock protein activation kinetics: Implications for treatment efficacy and safety. Transl Vis Sci Tecnol. 2020 Apr 28;9(5):23.doi: 10.1167/tvst.9.5.23. eCollection 2020 Apr.

46. Keunen JEE, Battaglia-Parodi M, Vujosevic S, Luttrull JK. International Retinal Laser Society Guidelines for Subthreshold Laser Treatment. Transl Vis Sci Technol. 2020 Aug 7;9(9):15. doi: 10.1167/tvst.9.9.15. eCollection 2020 Aug.PMID: 32879771 

47. Luttrull JK. Subthreshold diode micropulse laser (SDM) for persistent macular thickening and limited visual acuity after epiretinal membrane peeling. Clin Ophthalmol, April 2020: 14; 1177-1188

48. Luttrull JK, Sinclair SH, Elmann S, Chang DB, Kent D. Slowed progression of age-related geographic atrophy following subthreshold laser. Clin Ophthalmol (2020) Oct 1;14:2983-2993. doi:10.2147/OPTH.S268322. eCollection 2020

49. Al-Barki A, Al-Hijji L, High R, Schatz P, Do D, Nguyen QD, Luttrull JK, Kozak I. Comparison of short-pulse subthreshold (532 nm) and infrared micropulse (810 nm) macular laser for diabetic macular edema. Sci Rep. 2021 Jan 8;11(1):14. doi: 10.1038/s41598-020-79699-9. PMID: 33420100; PMCID: PMC7794500.

50. Luttrull JK, Gray G. Real World Data Comparison of Standard Care vs SDM Laser Vision Protection Therapy for Prevention of Neovascular AMD. Clin Ophthalmol (2022) May, 16: 1555-1568.

51. Sinclair SH, Luttrull JK. Diabetes Mellitus Associated Progressive Neurovascular Retinal Injury: Recommendations for Imaging and Functional Testing and Potential Role for Early Intervention with Modern Retinal Laser Therapy. J Ophth Rev Rep, July 2022 

52. Luttrull JK. Lasers in Medicine: The changing role of laser-induced retinal damage - from de riguer to Nevermore. Photonics 2023, 10(9), 999; https://doi.org/10.3390/photonics10090999

53. Luttrull JK, Gray G, Bhavan SV. Vision protection therapy for prevention of neovascular age-related macular degeneration. Sci Rep. 2023;13(1):16710. doi:10.1038/s41598-023-43605-w

54. Luttrull JK, Tzekov R, Bhavan SV. Progressive thickening of retinal nerve fiber and ganglion cell complex layers following SDM laser Vision Protection Therapy in Open Angle Glaucoma. Ophthalmol Ther  Sept 2024, https://doi.org/10.1007/s40123-024-01029-3

1. Grzybowski A, Luttrull JK, Kozak I, Eds. Retinal Lasers in Ophthalmology. Springer-Verlag, Berlin, Germany May 29, 2023 ISBN 978-30-3125-778-0

2. Luttrull JK. Modern Retinal Laser Therapy. Principles and Application. Kugler Publications, Amsterdam, The Netherlands August 2023 ISBN: 978-90-6299298-0

1. Luttrull JK: Subthreshold retinal photocoagulation for diabetic retinopathy. In Retinal and Vitreoretinal Diseases and Surgery, Boyd S, Cortez R, Sabates N eds. ISBN: 98-9962-678-23-6. Jaypee-Highlighlights Medical Publishers, Inc, Panama Rep. of Panama. 2010.  

2. Dorin G, Luttrull JK, Samples JR. Laser alteration of collector channel ostia. Pivotal paradigm shift from photocoagulation to photostimulation. Glaucoma Research and Clinical Advances: 2016 to 2018. Knepper and Samples, Eds. Kugler Pub. Jan 1, 2016, Amsterdam, Netherlands. ISBN: 9789062992478

3. Luttrull JK, Samples JR, Kent D, Lum BJ: Panmacular subthreshold diode micropulse laser (SDM) as neuroprotective therapy in primary open-angle glaucoma. Glaucoma Research 2018-2020, pp. 281-294 Edited by: John R. Samples and Paul A. Knepper © 2018 Kugler Publications, Amsterdam, The Netherlands

4. Luttrull JK, Kent D. Laser therapy to prevent choroidal neovascularization. Choroidal Neovascularization. Chhablanni J, Ed. Springer Verlag. July 2020. DOI: 10.1007/978-981-15-2213-0_30

5. Luttrull JK, Kent D. Modern retinal laser for neuroprotection in open-angle glaucoma. In: Samples JR, Ahmed IIK, eds. New Concepts in Glaucoma Surgery, Vol. 1. Amsterdam, Kugler Publications; Sept. 2019 ISBN-13: 978-1461483472, ISBN-10: 1461483476

6. Luttrull JK. Retinal Laser Treatment for Age-Related Macular Degeneration. Grzybowski A, Luttrull JK, Kozak I, Eds. Retinal Lasers in Ophthalmology. Springer-Verlag, Berlin, Germany May 29, 2023 ISBN 978-30-3125-778-0

7. Luttrull JK. The Future of Retinal Laser. Is there one? Grzybowski A, Luttrull JK, Kozak I, Eds. Retinal Lasers in Ophthalmology. Springer-Verlag, Berlin, Germany May 29, 2023 ISBN 978-30-3125-778-0

8. Luttrull JK. The Mechanism of Retinal Laser and Its End Result: Neuroprotection. Grzybowski A, Luttrull JK, Kozak I, Eds. Retinal Lasers in Ophthalmology. Springer-Verlag, Berlin, Germany May 29, 2023 ISBN 978-30-3125-778-0

9. Bhavan SV, Luttrull JK. Laser for Retinal Vascular Occlusions. Grzybowski A, Luttrull JK, Kozak I, Eds. Retinal Lasers in Ophthalmology. Springer-Verlag, Berlin, Germany May 29, 2023 ISBN 978-30-3125-778-0

10. Grzybowski A, Gaweki M, Luttrull JK. Laser Treatment of Diabetic Retinopathy. Grzybowski A, Luttrull JK, Kozak I, Eds. Retinal Lasers in Ophthalmology. Springer-Verlag, Berlin, Germany May 29, 2023 ISBN 978-30-3125-778-0

1. Luttrull, JK. "Shangricago". Guest editorial. Ojai Valley News June 1, 2005. (By invitation)

2. Luttrull, JK. Atraumatic photocoagulation for retinovascular disease. Case studies of micropulsed 810 nm diode laser photocoagulation in the management of diabetic retinopathy. Retinal Physician, 2005;2: 65-87. (By invitation)

3. Luttrull, JK. Is effective retinal photocoagulation without laser-induced damage possible? Retina Today, Winter 2006-07; 22-25. (By invitation)

4. Luttrull JK. Update on treatment of branch retinal vein occlusion. Subthreshold diode micropulse photocoagulation. Retina Today, August 2011. (By invitation)

5. Luttrull JK. Evolution of retinal laser surgery. Invisible retinal laser phototherapy for retinal vascular disease. Cataract and Refractive Surgery Today / Europe. Feb 2012: 70 – 72.  (By invitation)

6. Luttrull JK. Long-term safety of subvisible diode laser for diabetic macular edema. Ocular Surgery News. Feb 2012.  (By invitation)

7. Luttrull JK. Subthreshold diode micropulse laser for diabetic macular edema: Welcome to invisible retinal phototherapy! Ophthalmology Times Europe, June, 2013.   (By invitation)

8. Luttrull JK. Perspective on Visible Light Therapy as Prophylaxis Against Diabetic Retinopathy. Retinal Physician, March 2014, pg16-18.  (By invitation)

9. Luttrull JK. Journey to functionally guided retinal protective therapy for age-related and inherited retinopathies. Retina Today Oct 2015; 10 (7): 81-83.

10. Chhablani J, Luttrull JK, Lavinsky D, Sivraprasad S, Mansour S. Frequently asked questions about subthreshold retinal laser treatment. Retinal Physician, August 2016. 

11. Chhablani J, Luttrull JK. Navigated laser: The answer for DME? Debate. Retinal Physician June 2020.

1. Sinclair S, Luttrull JK, Cardillo J. Subthreshold diode micropulse photocoagulation for diabetic macular edema. American Society of Retina Specialists annual meeting August 2011, Boston, MA, USA.

2. Luttrull JK, Sinclair SD, Midena E. Instructors in clinical course, American Society of Retina Specialists annual meeting, Toronto, Canada, August 27, 2013.

3. Keunen J, Luttrull JK, Chong V, Midena E, Boon C. Clinical instructors for course in Subthreshold diode micropulse laser for diabetic macular edema. European Society of Retina Specialist annual meeting, Hamburg, Germany, Sept 27, 2013. 

4. Keunen J, Luttrull JK, Chong V, Midena E, Boon C. Clinical instructors for course in Subthreshold diode micropulse laser for diabetic macular edema. European Society of Retina Specialist annual meeting, London, England, Sept 12, 2014.

5. Keunen J, Luttrull JK, Chong V, Midena E, Boon C. Clinical instructors for course on subthreshold retinal laser treatment. European Society of Retina Specialist annual meeting, Nice, France, Sept 17, 2015.

6. Luttrull JK. Clinical use of micropulsed retinal lasers. European School of Advanced Studies in Ophthalmology, Feb 15, 2016. Rome, Italy. 

7. Keunen J, Midena E, Luttrull JK, Chong V. Subthreshold laser therapy. EURETINA, Annual meeting of the European Retina Society, Copenhagen, Denmark, September 2016. 

8. Keunen J, Luttrull JK, Midena E, Chong V. Subthreshold laser therapy. EURETINA, Annual meeting of the European Retina Society, Barcelona, Spain, October, 2017.

9. Luttrull JK, Dorin G. Modern Retinal Laser Therapy. European School for Advanced Studies in Ophthalmology, Lugano, Switzerland. February 2017.

10. Luttrull JK. Laser management of diabetic retinopathy. European School for Advanced Studies in Ophthalmology, Lugano, Switzerland. February 2017.

11. Keunen J, Luttrull JK, Midena E, Chong V. Subthreshold laser therapy. EURETINA, Annual meeting of the European Retina Society, Vienna, Austria, October, 2018.

12. Keunen J, Chong V, Midena E, Luttrull JK. Subthreshold retinal laser treatment. Educational course, Annual Meeting of the European Retina Society, Paris, France, Sept. 5, 2019. 

13. Gryzbowski A, Kirol A, Kozak I, Midena E, Luttrull JK. Retinal Laser. Educational course, Annual Meeting of the European Retina Society, Amsterdam (via Zoom), The Netherlands, Sept, 2021.

Approximately 200 patents issued and pending. These include the following core U.S. Patents:

1. U.S. Patent. No. 5,830,173. Avery RL, Luttrull JK:  Intraocular drug delivery device. Filed August 1, 1997.

2. U.S. Patent. No. 5,725,493. Avery RL, Luttrull JK:  Intraocular drug delivery device.  December 12, 1994.

3. U.S. Patent. No. 6,251,090 B1. Avery RL, Luttrull JK:  Intraocular drug delivery device.  November 2, 1998. 

4. U.S. Patent. No. 9308018. Awarded April 12, 2016. Micro vitreoretinal blades.

5. U.S. Patent. 14/607,959. Luttrull JK, Margolis BWL, Chang DB. Filed January 28, 2015. Issued September 4, 2015. Process for restoring responsiveness to medication in tissue of living organisms.

6. U.S. Patent. 9,381,115. Luttrull JK, Margolis BWL, Chang DB. Entitled: System and process for retina phototherapy. Filed May 12, 2012. Issued July 5, 2016. 

7. U.S. Patent. No. 9,381,116. Luttrull JK, Margolis BWL, Chang DB. Entitled: Subthreshold micropulse laser prophylactic treatment for chronic progressive retinal diseases. Filed: October 23, 2015. Issued July 5, 2016.

8. U.S. Patent. No. 9,427,602.  Pulsating electromagnetic and ultrasound for stimulating targeted heat shock proteins for achieve retinal repair. Filed Oct 26, 2015; issued August 30, 2016.

9. U.S. Patent. No. 9,962,291 System and process for neuroprotective therapy for glaucoma. Filed: August 9, 2016, awarded May 1, 2018.

10. U.S. Patent. No. 10,076,671 Apparatus for retinal phototherapy.  Filed July 1, 2016; awarded Sept 2018.

11. U.S. Patent. No. 10,117,777 System for neuroprotective therapy for glaucoma. Filed Oct 24, 2018. Awarded Nov 6, 2018.

12. U.S Patent. No. 10,194,798. Measuring RPE and choroid melanin levels with reflectometer.  Filed: November 20, 2017. Awarded: December 18, 2018.  Issued Feb 5, 2019.

13. U.S. Patent. No. 10,219,947. System and process for retina phototherapy. Filed March 13, 2013. Issued March 5, 2019.

14. U.S. Patent No. 10,238,542. System and process for retinal phototherapy. Filed June 6, 2016. Issued March 26, 2019.

15. U.S. Patent No. 10,278,865. Process for neuroprotective therapy for glaucoma. Filed May 3, 2016. Issued May 7, 2019.

16. U.S. Patent No. 10,285,859. System for performing retinal photostimulation. Filed October 22, 2016. Issued May 14, 2019.

17. U.S. Patent No. 10,299,961. System for neuroprotective therapy for glaucoma. Filed April 25, 2018. Issued May 28, 2019.

18. U.S. Patent No. 10,307,294, System and process for neuroprotection in glaucoma. Filed March 29, 2018. Issued June 4, 2019. 

19. U.S. Patent No. 10,357,398, System and process for treatment of myopia. Filed November 15, 2017. Issued July 23, 2019

20. U.S. Patent No. 10,363,171, System and process for retinal phototherapy. Filed May 6, 2016. Issued July 30, 2019.

21.U.S. Patent No.10,434,330, Process for safety providing retinal phototherapy by determining retinal melanin levels. Filed January 7, 2019. Issued October 10, 2019.

22. U.S Patent No. 10,531,098. Method for heat treating biological tissues using pulsed energy sources. Filed: July 20, 2016   Issued: January 14, 2020.

23. U.S Patent No. 10,596,389, Process and system for utilizing energy to treat biological tissue. 

Filed: July 18, 2018.   Issued: March 24, 2020.

24. U.S. Patent No. 10,709,608. System and process for prevention of myopia. Filed: June 13, 2019. Issued: July 14, 2020. 

25. U.S. Patent No. 10,709,607. System and process for prevention of myopia. Filed: May 21, 2019. Issued: July 14, 2020.

26. U.S. Patent No.10,874,873. Process utilizing pulsed energy to heat treat biological tissue. Filed: March 12, 2018. Issued Dec 13, 2020.

27. U.S. Patent No.10,894,169. System and method for preventing or treating Alzheimer’s and other neurodegenerative diseases.  Filed: Aug 4, 2020. Issued Jan 19, 2021

28. U.S. Patent No. 10,952,901. System and process for retinal phototherapy. Filed January 7, 2019. Issued March 23, 2021.

29. U.S. Patent No. 10,953,241. Process for providing protective therapy for biological tissues and fluids. Filed: May 1, 2017. Issued March 23, 2021.

30. U.S. Patent No. 10,952,899. Process for adjusting treatment parameters for retina phototherapy based on RPE melanin levels. Filed November 29, 2018. Issued March 23, 2021.

31. U.S. Patent No. 16/996,308. Process utilizing pulsed energy to heat treat biological tissue. Filed: August 18, 2020. Issued May 3, 2021.

32. U.S. Patent No. 11,033,749. Process utilizing pulsed energy to heat treat biological tissue. Filed: August 18, 2020. Issued June 15, 2021

33. U.S. Patent No. 11,077,318. System and process for utilizing energy for treating biological tissue. Filed: July 19, 2018. Issued August 3, 2021

34. U.S. Patent No. 11,679,272. Process for safely providing retinal phototherapy bvased on determination of RPE melanin levels. Issued June 30, 2023 

1. President, CEO, Regalo Extra Virgin Olive Oil, Inc., Ojai, CA. 2000-2020

2. Managing Member, Ojai Technologies, LLC, Ojai, CA.

3. Managing Member, Retinal Protective Sciences, LLC. Ojai, CA.

4. CMO, Vision Protection Institutes, Inc. Beverly Hills, CA.

5. CEO, Bethsaida Management Services, Inc, Los Angeles, CA.

6. Ojai Vivere, LLC. Management, equity

1. Surgical instrumentation.

2. Retinal laser.

3. Biotechnology.

1. IRIDEX Corp., Mountain View, California 2011-12

2. Ocular Proteomics LLC, Baltimore, MD 2016-18

1. Retinal laser.

2. Vitreoretinal surgery.

3. Restorative therapy for chronic disease

1. Regeneron Pharmaceuticals, Inc., A Randomized Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability or Repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration, VGFT-OD-0605 (VIEW 1) 

2. Genentech Pharmaceuticals, Inc., A phase III, Double-Masked, Multicenter, Randomized, Sham Injection -Controlled Study of the Efficacy and Safety of Ranibizumab injection in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus (RISE)-Protocol FVF4170G

PLoS ONE, Ophthalmology, Eye, British Journal of Ophthalmology, BMC Ophthalmology, American Journal of Ophthalmology, Graefe's Archive of Clinical and Experimental Ophthalmology, RETINA, Translational Vision Science and Technology, Investigative Ophthalmology and Visual Science, Ophthalmic Lasers, Surgery and Imaging, Ocular Pharmacology, Expert Review of Medical Devices, Acta Ophthalmologica, Advances in Therapy, Clinical and Experimental Optometry, Ophthalmology and Therapy, Clinical Ophthalmology, others.

Research Associates, Point Loma Nazarene University. 

Diabetes UK/United Kingdom National Health Service.

National Science Centre of Poland (Narodowe Centrum Nauki) OPUS grant reviewer